Don't cognize the stock symbol . (http://www.nasdaq.com/symbol/cara/insider-trades)

The companion is also developing Oral CR845, which is in Phase IIa clinical trials for the handling of moderate-to-severe sharp and habitual pain; and … . (http://aptly.us/chronicpain/2016/12/27/trader-alert-cara-therapeutics-inc-cara-nucor-corporation-nue-dollar-general/)

 Source: http://istreetwire.com/2016/12/27/trader-alert-cara-therapeutics-inc-cara-nucor-corporation-nue-dollar-general-corporation-dg/)